SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-16
👔
Cardiff Oncology, Inc.
@CRDF_InsiderForm 4 Filing: White Lale Acquires (Grant) shares of $CRDF
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Cardiff Oncology, Inc.
Ticker: $CRDF
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-11
Shares: 40,565
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, White Lale, holds the title of Director at Cardiff Oncology, Inc..
On 2026-06-11, the insider transacted 40,565 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
White Lale (Director) was granted $0 of $CRDF
Post-Transaction Position: 199,246 shares
SEC Accession No: 0001635493-26-000002 (CIK: 1635493)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.